|Table of Contents|

Research advances of vitamin D and its receptor in gynecologic cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 06
Page:
1129-1133
Research Field:
Publishing date:

Info

Title:
Research advances of vitamin D and its receptor in gynecologic cancer
Author(s):
YIN JunyangYE Yuan
Department of Gynaecology,Affiliated Hospital of Guilin Medical University,Guangxi Guilin 541001,China.
Keywords:
vitamin DVDRovarian cancercervical cancerendometrial carcinomavulvar cancervaginal cancer
PACS:
R737.3
DOI:
10.3969/j.issn.1672-4992.2022.06.038
Abstract:
In the past two decades,many studies have been concerned with the regulation mechanism of vitamin D and vitamin D receptor(VDR) in cancer.The 1,25(OH)2D3 is an active metabolite of vitamin D.It can not only maintain mineral homeostasis and bone dynamic balance,but also inhibit cell proliferation,induce cell differentiation,apoptosis and immune regulation.In recent years,more and more research evidence shows that vitamin D and VDR play an important role in the pathogenesis of gynecological cancer.It is a new entry point in the study of gynecological cancer treatment.In this paper,the status of vitamin D and its receptors in gynecological malignancies will be reviewed.

References:

[1]CHRISTAKOS S,DHAWAN P,VERSTUYF A,et al.Vitamin D:metabolism,molecular mechanism of action,and pleiotropic effects[J].Physiological Reviews,2016,96(1):365-408.
[2]NAKAMURA K,SMYTH MJ.Targeting cancer-related inflammation in the era of immunotherapy[J].Immunology and Cell Biology,2017,95(4):325-332.
[3]GEMBILLO G,CERNARO V,SALVO A,et al.Role of vitamin D status in diabetic patients with renal disease[J].Medicina(Kaunas,Lithuania),2019,55(6):273.
[4]ZHOU W,WANG Q.Vitamin D suppresses lipopolysaccharide-induced inflammatory response in vascular smooth muscle cells via inhibition of the p38 MAPK signaling pathway[J].Die Pharmazie,2019,74(3):168-174.
[5]LIN Z,LI W.The roles of vitamin D and its analogs in inflammatory diseases[J].Current Topics in Medicinal Chemistry,2016,16(11):1242-1261.
[6]CASTELLANO-CASTILLO D,MORCILLO S,CLEMENTE-POSTIGO M,et al.Adipose tissue inflammation and VDR expression and methylation in colorectal cancer[J].Clin Epigenetics,2018,10:60.
[7]FERRER-MAYORGA G,LARRIBA MJ,CRESPO P,et al.Mechanisms of action of vitamin D in colon cancer[J].The Journal of Steroid Biochemistry and Molecular Biology,2019,185:1-6.
[8]YANG L,WU L,ZHANG X,et al.1,25(OH)2D3/VDR attenuates high glucose-induced epithelial-mesenchymal transition in human peritoneal mesothelial cells via the TGFβ/Smad3 pathway[J].Molecular Medicine Reports,2017,15(4):2273-2279.
[9]CZARES-ORDOEZ V,GONZLEZ-DUARTE RJ,DAZ L,et al.A cis-acting element in the promoter of human ether à go-go 1 potassium channel gene mediates repression by calcitriol in human cervical cancer cells[J].Biochemistry and Cell Biology,2015,93(1):94-101.
[10]KIZILDAG S,ATES H,KIZILDAG S.Treatment of K562 cells with 1,25-dihydroxyvitamin D3 induces distinct alterations in the expression of apoptosis-related genes BCL2,BAX,BCLXL,and p21[J].Ann Hematol,2010,89(1):1-7.
[11]KIM TH,PARK J,LEE JS,et al.Effects of 1alpha,25-dihydroxyvitamin D(3) on programmed cell death of Ishikawa endometrial cancer cells through ezrin phosphorylation[J].Journal of Obstetrics and Gynaecology,2017,37(4):503-509.
[12]SERGEEV IN.Vitamin D status and vitamin D-dependent apoptosis in obesity[J].Nutrients,2020,12(5):1392.
[13]BROZYNA AA,JOZWICKI W,JETTEN AM,et al.On the relationship between VDR,RORα and RORγ receptors expression and HIF1-α levels in human melanomas[J].Experimental Dermatology,2019,28(9):1036-1043.
[14]AGGARWAL A,FELDMAN D,FELDMAN BJ.Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression[J].The Journal of Steroid Biochemistry and Molecular Biology,2018,177:155-158.
[15]BOKHARI AA,LEE LR,RABOTEAU D,et al.Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1[J].Oncotarget,2016,7(47):77576-77590.
[16]LONG M,ROJO DE LA VEGA M,WEN Q,et al.An essential role of NRF2 in diabetic wound healing[J].Diabetes,2016,65(3):780-793.
[17]赵钦,杨志勇,庄则豪.维生素D的抗肿瘤作用与食管癌[J].肿瘤代谢与营养电子杂志,2017,4(03):258-262. ZHAO Q,YANG ZY,ZHUANG ZH.The antitumor effect of vitamin D and esophageal cancer[J].Electronic Journal of Tumor Metabolism and Nutrition,2017,4(03):258-262.
[18]COLONESE F,LAGAN AS,COLONESE E,et al.The pleiotropic effects of vitamin D in gynaecological and obstetric diseases:an overview on a hot topic[J].BioMed Research International,2015,2015:986281.
[19]杨伟杰,赵伟鑫,刘永亮,等.维生素D受体研究进展[J].河南科技学院学报(自然科学版),2019,47(05):46-51. YANG WJ,ZHAO WX,LIU YL,et al.Research progress of vitamin D receptor[J].Journal of Henan University of Science and Technology(Natural Science Edition),2019,47(05):46-51.
[20]LISSE TS,HEWISON M,ADAMS JS.Hormone response element binding proteins:novel regulators of vitamin D and estrogen signaling[J].Steroids,2011,76(4):331-339.
[21]LA MARRA F,STINCO G,BULIGAN C,et al.Immunohistochemical evaluation of vitamin D receptor(VDR) expression in cutaneous melanoma tissues and four VDR gene polymorphisms[J].Cancer Biology & Medicine,2017,14(2):162-175.
[22]DEUSTER E,JESCHKE U,YE Y,et al.Vitamin D and VDR in gynecological cancers-a systematic review[J].International Journal of Molecular Sciences,2017,18(11):2328.
[23]GUO H,GUO J,XIE W,et al.The role of vitamin D in ovarian cancer:epidemiology,molecular mechanism and prevention[J].Journal of Ovarian Research,2018,11(1):71.
[24]HOU YF,GAO SH,WANG P,et al.1α,25(OH)2D3 suppresses the migration of ovarian cancer SKOV-3 cells through the inhibition of epithelial-mesenchymal transition[J].International Journal of Molecular Sciences,2016,17(8):1285.
[25]LUNGCHUKIET P,SUN Y,KASIAPPAN R,et al.Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptor[J].The Journal of Steroid Biochemistry and Molecular Biology,2015,148:138-147.
[26]CHEN Y,SUN Z,XU J,et al.Vitamin D and DDX4 regulate the proliferation and invasion of ovarian cancer cells[J].Oncology Letters,2018,16(1):905-909.
[27]JAVADI S,GANESHAN DM,QAYYUM A,et al.Ovarian cancer,the revised FIGO staging system,and the role of imaging[J].American Journal of Roentgenology,2016,206(6):1351-1360.
[28]AHONEN MH,ZHUANG YH,AINE R,et al.Androgen receptor and vitamin D receptor in human ovarian cancer:growth stimulation and inhibition by ligands[J].International Journal of Cancer,2000,86(1):40-46.
[29]LACZMANSKI L,LWOW F,OSINA A,et al.Association of the vitamin D receptor FokI gene polymorphism with sex-and non-sex-associated cancers:A meta-analysis[J].Tumour Biology,2017,39(10):1010428317727164.
[30]YABUSHITA H,HIRATA M,NOGUCHI M,et al.Vitamin D receptor in endometrial carcinoma and the differentiation-inducing effect of 1,25-dihydroxyvitamin D3 on endometrial carcinoma cell lines[J].The Journal of Obstetrics and Gynaecology Research,1996,22(6):529-539.
[31]AGIC A,XU H,ALTGASSEN C,et al.Relative expression of 1,25-dihydroxyvitamin D3 receptor,vitamin D 1 alpha-hydroxylase,vitamin D 24-hydroxylase,and vitamin D 25-hydroxylase in endometriosis and gynecologic cancers[J].Reproductive Sciences(Thousand Oaks,Calif.),2007,14(5):486-497.
[32]LEE LR,TENG PN,NGUYEN H,et al.Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells[J].Cancer Prevention Research(Philadelphia,Pa.),2013,6(7):731-743.
[33]KUITTINEN T,ROVIO P,STAFF S,et al.Paclitaxel,carboplatin and 1,25-D3 inhibit proliferation of endometrial cancer cells in vitro[J].Anticancer Research,2017,37(12):6575-6581.
[34]曹蕾,上官改珍,白雯.1,25-(OH)2D3在宫颈良性病变和宫颈癌患者中的表达水平及临床意义[J].实用癌症杂志,2019,34(09):1409-1411. CAO L,SHANGGUAN GZ,BAI W.The expression level and clinical significance of 1,25-dihydroxyvitamin D3 in patients with cervical benign lesions and cervical cancer[J].Journal of Practical Cancer,2019,34(09):1409-1411.
[35]VAHEDPOOR Z,JAMILIAN M,BAHMANI F,et al.Effects of long-term vitamin D supplementation on regression and metabolic status of cervical intraepithelial neoplasia:a randomized,double-blind,placebo-controlled trial[J].Hormones & Cancer,2017,8(1):58-67.
[36]WANG G,LEI L,ZHAO X,et al.Calcitriol inhibits cervical cancer cell proliferation through downregulation of HCCR1 expression[J].Oncology Research,2014,22(5-6):301-309.
[37]AVILA E,GARCA-BECERRA R,RODRGUEZ-RASGADO JA,et al.Calcitriol down-regulates human ether a go-go 1 potassium channel expression in cervical cancer cells[J].Anticancer Research,2010,30(7):2667-2672.
[38]SALEHIN D,HAUGK C,THILL M,et al.Vitamin D receptor expression in patients with vulvar cancer[J].Anticancer Research,2012,32(1):283-289.

Memo

Memo:
广西重点研发计划项目(编号:桂科AB17292092)
Last Update: 1900-01-01